Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer.
Hanna PE, Wang Q, Strohbehn IA, Moreno D, Harden D, Ouyang T, Katz-Agranov N, Seethapathy H, Reynolds KL, Gupta S, Leaf DE, Sise ME. Hanna PE, et al. Among authors: harden d. JAMA Netw Open. 2023 Jul 3;6(7):e2321715. doi: 10.1001/jamanetworkopen.2023.21715. JAMA Netw Open. 2023. PMID: 37405775 Free PMC article.
Comparison of short- and long-term adverse kidney outcomes after chimeric antigen receptor T cell therapy and autologous hematopoietic stem cell transplant for diffuse large B cell lymphoma.
Hanna P, Strohbehn I, Moreno D, Harden D, Seethapathy H, Gupta S, Lee M, Ouyang T, Frigault M, Sise ME. Hanna P, et al. Among authors: harden d. Bone Marrow Transplant. 2022 Oct;57(10):1623-1625. doi: 10.1038/s41409-022-01767-7. Epub 2022 Aug 3. Bone Marrow Transplant. 2022. PMID: 35922564 No abstract available.
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
Sise ME, Wang Q, Seethapathy H, Moreno D, Harden D, Smith RN, Rosales IA, Colvin RB, Chute S, Cornell LD, Herrmann SM, Fadden R, Sullivan RJ, Yang NJ, Barmettler S, Wells S, Gupta S, Villani AC, Reynolds KL, Farmer J. Sise ME, et al. Among authors: harden d. J Immunother Cancer. 2023 Jan;11(1):e006222. doi: 10.1136/jitc-2022-006222. J Immunother Cancer. 2023. PMID: 36657813 Free PMC article.
Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer.
Hanna PE, Strohbehn IA, Moreno D, Harden D, Seethapathy R, Sawtell R, Wang Q, Ouyang T, Katz-Agranov N, Dinulos J, Wander SA, Gupta S, Sise ME. Hanna PE, et al. Among authors: harden d. NPJ Breast Cancer. 2023 Aug 19;9(1):70. doi: 10.1038/s41523-023-00576-5. NPJ Breast Cancer. 2023. PMID: 37598278 Free PMC article.
Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer.
Hanna PE, Ouyang T, Tahir I, Katz-Agranov N, Wang Q, Mantz L, Strohbehn I, Moreno D, Harden D, Dinulos JE, Cosar D, Seethapathy H, Gainor JF, Shah SJ, Gupta S, Leaf DE, Fintelmann FJ, Sise ME. Hanna PE, et al. Among authors: harden d. J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):1187-1198. doi: 10.1002/jcsm.13469. Epub 2024 Apr 22. J Cachexia Sarcopenia Muscle. 2024. PMID: 38646842 Free article.
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis.
Zhang X, Jiang W, Richter JM, Bates JA, Reznik SK, Stachura S, Rampulla R, Doddalingappa D, Ulaganathan S, Hua J, Bostwick JS, Sum C, Posy S, Malmstrom S, Dickey J, Harden D, Lawrence RM, Guarino VR, Schumacher WA, Wong P, Yang J, Gordon DA, Wexler RR, Priestley ES. Zhang X, et al. Among authors: harden d. J Med Chem. 2024 Mar 14;67(5):3571-3589. doi: 10.1021/acs.jmedchem.3c01986. Epub 2024 Feb 22. J Med Chem. 2024. PMID: 38385264
54 results